A/Prof Taixiang Wu, Associate Professor, Chinese Cochrane Centre, Chinese EBM Centre, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041, CHINA. email@example.com.
This is the protocol for a review and there is no abstract. The objectives are as follows:
To evaluate the effectiveness and safety of the alkylating agents for Waldenstrom Macroglobulinemia